Nomoto A, Mutoh S, Hagihara H, Yamaguchi I
Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Ibaraki, Japan.
Atherosclerosis. 1988 Aug;72(2-3):213-9. doi: 10.1016/0021-9150(88)90083-4.
The chemotactic activities of inflammatory cell products for rat aortic smooth muscle cells (SMC) were examined in modified Boyden chambers. A checker board analysis revealed that interleukin-1 (IL-1), leukotriene B4 (LTB4), platelet-derived growth factor (PDGF) and inflammatory exudate from zymosan-activated air pouches stimulated chemotaxis of SMC. The chemotaxis, irrespective of the attractants used, was strongly inhibited by nilvadipine, a potent calcium antagonist, and the IC50 values were around 1 x 10(-10) M. Removal of extracellular calcium abolished the chemotactic activities of the attractants. These results suggest that inflammatory cells such as macrophages and polymorphonuclear leukocytes (PMN) have an important role in the migration of SMC into the intima during atherogenesis, and that nilvadipine might be useful for preventing and treating atherosclerosis.
在改良的Boyden小室中检测了炎性细胞产物对大鼠主动脉平滑肌细胞(SMC)的趋化活性。棋盘分析显示,白细胞介素-1(IL-1)、白三烯B4(LTB4)、血小板衍生生长因子(PDGF)以及来自酵母聚糖激活气囊的炎性渗出物可刺激SMC的趋化作用。无论使用何种趋化剂,趋化作用均被强效钙拮抗剂尼伐地平强烈抑制,IC50值约为1×10⁻¹⁰ M。去除细胞外钙可消除趋化剂的趋化活性。这些结果表明,巨噬细胞和多形核白细胞(PMN)等炎性细胞在动脉粥样硬化形成过程中SMC向内膜迁移中起重要作用,且尼伐地平可能对预防和治疗动脉粥样硬化有用。